Annotation Detail

Information
Associated Genes
ATM
Associated Variants
ATM MUTATION
ATM MUTATION
Associated Disease
prostate cancer
Source Database
CIViC Evidence
Description
Response to olaparib was observed in 4 of 5 with prostate cancer patients with ATM aberrations (2 germline).
Variant Origin
germline
Variant Origin
Rare Germline
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1960
Gene URL
https://civic.genome.wustl.edu/links/genes/69
Variant URL
https://civic.genome.wustl.edu/links/variants/178
Rating
3
Evidence Type
Predictive
Disease
Prostate Cancer
Evidence Direction
Supports
Drug
Olaparib
Evidence Level
C
Clinical Significance
Sensitivity/Response
Pubmed
26510020
Drugs
Drug NameSensitivitySupported
OlaparibSensitivitytrue